BRCA1 and ovarian carcinoma: We found that BRCA1 promoter methylation was present in 10.3% of unselected ovarian cancer cases and in 6.5% of healthy controls, what corresponded to slightly (about 50%) increased risk of ovarian cancer (OR 1.65, 1.12-2.40, p = 0.01).